Amid New Price Highs, Ether Flips Bitcoin on Options Volume

Business

CoinDesk 04 May, 2021 - 06:32am 13 views

How much will ethereum be worth?

Basic Info. Ethereum Price is at a current level of 3286.22, down from 3431.41 yesterday and up from 206.94 one year ago. This is a change of -4.23% from yesterday and 1.49K% from one year ago. ycharts.comEthereum Price

Ether's options market saw record trading volume of $1.32 billion on Monday, far above bitcoin's $879 million.

The “flippening,” along with ether’s strong price performance in recent weeks, is a further sign of market focus temporarily shifting away from bitcoin, the top crypto asset by market value.

On Monday, four larger exchanges offering ETH options – Deribit, OKEx, Huobi, and bit.com – registered a combined trading volume high of $1.32 billion, surpassing bitcoin’s tally for the first time on record. Bitcoin’s options market traded contracts worth $879 million on the same day, according to data source Skew. 

Ether’s options volume soared as prices for the native token of the Ethereum blockchain rose toward a new lifetime high above $3,400 reached Tuesday. While ether has rallied by over 60% in the past four weeks, bitcoin has dropped by 3%, according to CoinDesk 20 data. 

Options are derivatives contracts that give the purchaser the right but not the obligation to buy the underlying asset at a predetermined price on or before a specific date. A call option gives the right to purchase, and the put represents the right to sell. 

The data represents a shift in investor focus from bitcoin to ether, with Ethereum seeing solid organic growth this year, as recently tweeted by DTC Capital’s Spencer Noon. 

A report published by digital-asset manager CoinShares on April 26 showed that ether funds and investment products saw an inflow of $34 million in the third week of April, while bitcoin funds lost $21 million.

“New investor money has been flowing into digital assets since the 3rd quarter of last year, but the investor goals are changing,” Jeff Dorman, chief investment officer at Arca, noted in a market recap published on Monday. “And in the last few months, the investor interest has narrowed even further to ‘can I specifically diversify away from Bitcoin into Ethereum and other digital assets?'”

Analysts foresee a continued bull run in ether, with some betting on a rally to $10,000. Therefore, more traders and investors could join ether’s derivatives market in a bid to hedge their spot market exposure, or to take plain bullish or bearish bets. 

At press time, ether’s options market is decisively bullish on the cryptocurrency with one, three and six-month put-call skews trading well below zero – a sign of calls (bullish bets) drawing higher than demand than puts. 

Read full article at CoinDesk

What Will the Stock Market Do Today? 3 Big Stories to Watch.

InvestorPlace 04 May, 2021 - 09:00am

Millions of People Will Soon Be Blindsided. Will You Be One of Them?

On April 20 at 7 p.m. ET, Louis Navellier and Matt McCall will reveal an event that’s about to rock the stock market and how you could use it to beat the markets by nearly 11X.

Coinbase starts trading today and Dogecoin just hit an all-time high

Good morning and welcome to the stock market today! Dive in with InvestorPlace below for more on the red-hot Coinbase IPO and everything else investors can expect the stock market to do today.

To start, the major indices are all gaining on Wednesday morning. The S&P 500 is up 0.16%, while the Dow Jones Industrial Average is up 0.6%. The Nasdaq Composite is also in the green, up slightly to kick off the day.

So what else will the stock market do today? Check out the top stories.

Today, Coinbase will start trading on the Nasdaq Exchange, and Wall Street is paying close attention.

Largely, that is because of what Coinbase represents to crypto bulls, and what it means for individual cryptocurrencies. As we have previously written, Coinbase has a known effect on the cryptos listed on its platform. Tokens see an average return of more than 90% in the first few days after their listing — high than on any other exchange. That has investors paying close attention to a handful of altcoins following their recent listings. Coinbase is also the second-largest cryptocurrency exchange in the world.

And importantly, it is the largest crypto startup to list on a major U.S. exchange yet.

As Erin Griffith wrote for the New York Times, many crypto bulls see the Coinbase IPO today as vindication, as proof as Bitcoin (CCC:BTC-USD), Ethereum (CCC:ETH-USD) and so many other coins merit the hype. You can consider it a coming-out party as Griffith calls it, or perhaps a debutante ball.

As you prepare for COIN stock to make a splash when it starts trading, consider these stories from InvestorPlace. Make sure to prep your mind and your portfolio for the Coinbase IPO:

Dogecoin (CCC:DOGE-USD) is on fire.

Investors have been barking up the meme-coin all week, and it is really paying off. For the first time ever, DOGE traded above the 14-cent mark, setting a new all-time high. This also means that Dogecoin has posted simply impressive gains so far this year, up 2,000%. This is likely not entirely surprising to crypto bulls, especially with analysts continuing to up their Dogecoin price predictions.

But how far can DOGE go? As critics are quick to point out, the altcoin was created by its founders to be a joke. That could keep it from getting the type of institutional backing that Bitcoin and Ethereum are now.

However, Dogecoin has some powerful forces on its side. Celebrity backers like Elon Musk continue to tote the coin, promising to take it to the actual moon. The Mavericks began accepting it as a payment for tickets and merchandise. The passionate #DogeArmy promises to take DOGE to $1 as soon as possible.

InvestorPlace Markets Analyst Tom Yeung thinks there is a path for DOGE to reach $10, as long as two things happen. The first is that Dogecoin needs to address its inflationary structure. Unlike Bitcoin, of which there is a limited supply of tokens, more DOGE gets minted every day. Because of this, Yeung says it will be hard for Dogecoin to sustain the huge gains we have seen in BTC. Additionally, Yeung says that some of its high-profile backers need to put their money where their mouths are. In other words, although Musk is responsible for several short-term rallies, he could take DOGE to $10 if he started a charitable Dogecoin foundation to fund development. Investors who want to see that happen need to be ready to contribute.

You can read more about the case for Dogecoin to reach $10 here.

Article printed from InvestorPlace Media, https://investorplace.com/2021/04/what-will-the-stock-market-do-today-3-big-stories-coinbase-ipo-dogecoin-prices/.

Ether’s 1,500% Jump Is Just the Start for Crypto Faithful

Yahoo Canada Finance 04 May, 2021 - 06:10am

Cryptocurrency enthusiasts are scaling up price targets for Ether after the second-largest token’s record-breaking run, an echo of the unbridled optimism that accompanied an earlier surge in Bitcoin.

The token affiliated with the Ethereum blockchain -- a digital ledger popular for financial services and sales of so-called cryptocollectibles like online art -- is up about 1,500% in the past year and hit a new peak of $3,455 on Tuesday.

The climb is stirring predictions of more gains ahead even as some technical indicators flash warnings that the rally may be overextended. Crypto proponents argue investors are now looking beyond Bitcoin to Ether and other tokens despite warnings of a stimulus-fueled mania in the sector.

“The market is realizing how fundamentally undervalued Ether is given all the development activity on the network,” said Vijay Ayyar, head of Asia Pacific at crypto exchange Luno Pte. “While one may think Ether has risen a lot, when you compare it to Bitcoin, there is a long way to go.”

Ayyar sees Ether hitting $5,000 to $10,000 by early next year. Evercore ISI technical strategist Rich Ross has revised up his target to $4,100 from $3,900. Many traders are eyeing a run toward $10,000 before the end of 2021, Edward Moya, a senior market analyst at Oanda Corp., wrote in a note.

“Ether will have much volatility, similar to Bitcoin, but can increase in value as more institutional investors become aware of it,” Pat LaVecchia, chief executive officer of crypto broker Oasis Pro Markets LLC, wrote in an email. Ether at $25,000 is possible over the next few years, he said.

Optimists typically cite Ether’s use in applications on the Ethereum blockchain, as well as upgrades to the network to make it more efficient, as among the reasons for their bullishness.

In the futures market, Ether volumes are getting closer to those of Bitcoin contracts, even though CME Group Inc. only launched the former in February.

Still, there are indications that Ether’s rally is getting stretched. The token’s 14-day relative strength index has risen above 70 to the highest since January, signaling it may have climbed too far, too quickly.

Luno’s Ayyar said any run like Ether’s is bound to correct, but added that he views its long-term outlook as “very healthy.”

Ether rose 4.2% to $3,425 as of 7:07 a.m. in New York, outperforming the wider Bloomberg Galaxy Crypto Index.

For more articles like this, please visit us at bloomberg.com

Subscribe now to stay ahead with the most trusted business news source.

Yogesh Raj, a former Bajrang Dal worker, defeated Independent candidate Nirdosh Chaudhary by 2,150 votes

Soldiers A and C had been accused of the murder of Official IRA leader Joe McCann in 1972.

This Powerful Solution Accelerates Math Growth for K-12 StudentsRed Bank, NJ, May 04, 2021 (GLOBE NEWSWIRE) -- Achieve3000, the leader in learning acceleration for PreK-12 students, today announced that Achieve3000 Math™ , its personalized math instruction solution, has been selected as a 2021 EdTech Cool Tool Awards finalist in the category of Math Solution. Introduced in fall 2020, Achieve3000 Math is designed to develop math fluency and accelerate K-12 students’ mastery of skills across grades, standards, and topics. Like Achieve3000 Literacy™, it uses differentiated practice and intervention to close knowledge gaps and build confidence. Achieve3000 Math is aligned to The Quantile Framework® for Mathematics from MetaMetrics® and utilizes proven-effective content and functionality to accelerate student gains in math. Each student’s progress is tracked in real time, offering unprecedented access for monitoring, reporting, instructional planning, and assessment. “We are honored that EdTech Digest has selected Achieve3000 Math as a Cool Tool,” said Stuart Udell, CEO of Achieve3000. “I’d like to give kudos to the people on our product development team who have worked very hard to make Achieve3000 Math not just a rigorous instructional tool, but also a powerful, personalized learning experience.” For more than a decade, the EdTech Awards have been shining a spotlight on cool tools, inspiring leaders, and innovative trendsetters across the K-12, Higher Education, and Skills and Workforce sectors. About Achieve3000 Achieve3000 delivers a comprehensive suite of digital solutions that significantly accelerate and deepen learning in literacy, math, science, social studies, and ELA. Using personalized and differentiated solutions, Achieve3000 enables educators to help all students achieve accelerated growth. For more than five million students in grades PreK-12, Achieve3000 improves high-stakes test performance and drives college and career readiness. CONTACT: Rebecca Salem Achieve3000 7323675505 media@achieve3000.com

Life Spine, a leading medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the PROLIFT Lateral HELO Fixation System.

Lily James stars opposite Sebastian Stan as Pamela Anderson, while he portrays Tommy Lee in the upcoming Hulu limited series

The Canadian dollar weakened against its U.S. counterpart on Tuesday as the greenback broadly climbed and data showed Canada's trade balance swinging to a surprise deficit in March, with the loonie pulling back from a recent 3-year high. Canada's trade deficit was C$1.1 billion in March, Statistics Canada said. Robust housing construction and resales have bolstered the outlook for Canada's economy after it was hammered in 2020 by the coronavirus crisis.

Zoo authorities in the southern state of Hyderabad shared samples with a government research laboratory on March 24 after the lions showed signs of respiratory distress. "Based on experience with zoo animals elsewhere in the world that have experienced SARS-COV2 positive last year, there is no factual evidence that animals can transmit the disease to humans any further," the Ministry of Environment, Forest and Climate Change said. India has reported more than 300,000 daily COVID-19 infections for 13 straight days and has now recorded 20 million cases of the disease, the second highest number in the world after the United States.

Number 10 has refused to deny reports that Conservative donors were approached to pay childcare costs for Boris Johnson's son. At the weekend, an MP was claimed to have received a complaint from a Tory donor that they were asked to foot the bill for Mr Johnson's one-year-old child Wilfred with his fiancee, Carrie Symonds. According to the Sunday Times, one donor is alleged to have said: "I don't mind paying for leaflets but I resent being asked to pay to literally wipe the prime minister's baby's bottom."

Trametria Baldwin of Dallas faces a charge of murder in the killing of a 57-year-old Garland, TX woman on Saturday.

(Bloomberg) -- Pfizer Inc. laid out a plan to turn its Covid-19 vaccine into a long-term business, clinching supply agreements that will yield $26 billion in sales this year while expanding the shot to children and developing new formulations that can combat variants and be stored more easily.The drugmaker’s revenue forecast was an increase from $15 billion, a reflection of strong demand worldwide for a return to normalcy. Pfizer said it now expects to deliver 1.6 billion doses this year under contracts signed as of mid-April, with half the profits going to partner BioNTech SE.The company will add $500 million to its research and development spending this year to invest in Covid-19 treatments and other vaccines using the cutting-edge messenger RNA technology. That investment comes as Chief Executive Officer Albert Bourla bets Covid-19 will become endemic, requiring people to get regular shots for years to come.“Based on what we’ve seen, we believe that a durable demand for our Covid-19 vaccine -– similar to that of the flu vaccines –- is a likely outcome,” Bourla said in remarks prepared for a Tuesday analyst call.Shares of Pfizer were up less than 1% to $40.04 at 10:24 a.m. in New York trading. Through the close of trading on Monday, the drugmaker had gained 8.2% this year.In the first quarter, the BNT162b2 Covid-19 vaccine drew $3.5 billion in sales, based on deliveries to more than 50 countries, the New York-based company said in its statement Tuesday. “We also are in ongoing discussions with multiple countries around the world about their needs,” Bourla said, “and we expect these discussions to lead to additional supply agreements.”Meanwhile, the vaccine partners are studying their shot in children ages 6 months to 11 years old. Pfizer expects to seek an emergency-use authorization for two cohorts (age 2 to 5, and 5 to 11) in September, and for those six months to 2 years in the fourth quarter. Clearance is expected imminently for those 12 to 15.Next-Generation ShotBourla said Pfizer is testing a third dose of the existing formulation of its Covid shot to determine whether a booster provides protection against SARS-CoV-2 virus variants currently in circulation.The company has begun evaluating an updated formulation that encodes the spike protein of the variant first identified in South Africa. “This study is designed to establish a regulatory pathway to update the current vaccine to address any future variant of potential concern in approximately 100 days,” Bourla said.Pfizer expects immunogenicity data for both studies in early July. That month, or in early August, the company will also report safety data from an ongoing study of the vaccine in pregnant women.Improving DeliveryAs the drug giant seeks to expand the vaccine’s use to younger populations, test third-dose boosters, and develop reformulated shots that combat variants, it’s also aiming to improve delivery.On Friday, Pfizer approached U.S. regulators with data that would support the vaccine being stored at standard refrigerator temperatures for as long as four weeks. It’s also working on a new formulation that could be stored in a refrigerator for 10 weeks, and as long as six months at -50° to -70° centigrade. Bourla said he expects data from this formulation in August.Separately, Pfizer is testing two antiviral candidates -- one drug given intravenously, one pill -- to treat patients who have contracted Covid. The former will launch into late-stage studies in May, while the latter will kick start in July.Altogether, Pfizer is boosting its full-year guidance for adjusted research and development expenses in a range of $9.8 billion to $10.3 billion “to incorporate anticipated spending on incremental Covid-19 related programs and other mRNA-based projects that are not part of the BioNTech collaboration,” Chief Financial Officer Frank D’Amelio said in prepared remarks.Pfizer and BioNTech are splitting R&D costs related to their vaccine.2022 ProductionPfizer and BioNTech will have the capacity to produce at least 3 billion doses in 2022. The companies have already made progress in securing vaccine contracts into the future.Pfizer has signed a supply agreement with Israel to provide enough Covid shots to protect every eligible citizen in 2022, Bourla said, and with Canada to supply as many as 125 million doses in 2022 and 2023, with options of 60 million additional doses in 2024.But some on Wall Street remain skeptical that the Pfizer-BioNTech partnership can maintain high demand for its vaccine well into the future.“Sales are clearly exceeding expectations, and this trend likely continues into 2022,” said JPMorgan analyst Chris Schott in a note to investors. “However, these sales are unlikely to be sustainable anywhere near current levels longer-term.”Beyond CovidPfizer’s foray into messenger RNA, the new technology that’s been validated in the pandemic, goes well beyond its Covid vaccine, according to Bourla.The company will move two mRNA flu shots into clinical trials come the third quarter, and will also explore using the technology to address other infectious diseases, cancers and genetic disease.Excluding the vaccine, Pfizer’s core drug business showed significant growth, leading it to raise revenue guidance specific to that portfolio by $200 million for the year. The results were stronger than some rivals who saw sales suffer in the first quarter after a new surge in U.S. virus cases.Overall, revenue in the quarter was $14.58 billion, stronger than the $13.62 billion that analysts had expected on average, according to data compiled by Bloomberg. First-quarter adjusted earnings per share were 93 cents, up 47% from 63 cents a year ago.Blood thinner Eliquis sales grew 25% year-over-year to $1.65 billion, topping Wall Street estimates. Breast cancer drug Ibrance and its Prevnar vaccine franchise, however, underperformed analysts’ expectations.(Updates throughout)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.

Lucknow (Uttar Pradesh) [India], May 4 (ANI): At a time when no one pays attention to stray animals due to the COVID crisis and the lockdown, Additional Deputy Commissioner of Police, Central Lucknow, Chiranjeev Nath Sinha and his police team distributed bananas and chickpea to stray monkeys and cows in Lucknow on Tuesday.

Omnium Event Manager provides institutional investors with a consolidated view of corporate action and dividend events affecting fund portfolios.

SAN DIEGO, May 04, 2021 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Franklin Wireless Corp. (NASDAQ: FKWL) shares. Investors, who purchased shares of Franklin Wireless Corp. (NASDAQ: FKWL) prior to September 2020 and continue to hold any of their Franklin Wireless Corp. (NASDAQ: FKWL) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1 (858) 779 - 1554. The plaintiff alleged that the defendants failed to disclose to investors that Franklin’s hotspot devices suffered from battery issues, including overheating, thereby presenting a fire hazard, that, as a result, it was reasonably likely that the Company’s customers would recall Franklin’s devices, that, as a result, Franklin would suffer reputational harm, and that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Those who purchased Franklin Wireless Corp. (NASDAQ: FKWL) shares should contact the Shareholders Foundation, Inc. CONTACT: Shareholders Foundation, Inc. Michael Daniels +1 (858) 779-1554 mail@shareholdersfoundation.com 3111 Camino Del Rio North Suite 423 San Diego, CA 92108 The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and a settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. Any referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is only provided as a public service. It is not intended as legal advice and should not be relied upon.

TOKYO, May 04, 2021 (GLOBE NEWSWIRE) -- Recently, Cullman Mutual Capital has released the report on the recent economic rebound from the global coronavirus pandemic. Global financial equities have seen a recent surge due to a combination of positive corporate earnings and strong economic data, signalling a recovery from the global coronavirus pandemic as outlined by Tokyo-based asset management company Cullman Mutual Capital. With a clear influx of new economic data that has indicated the U.S. economy is, in fact, growing, financial markets around the world have rallied on the back of the uplifting news. "We have seen that financial equities have been rallying higher across all markets due to expectations of an economic recovery across the globe, with more countries providing vaccination programs and helping them return to work. There has been a huge boost on increased consumer spending which ultimately has driven corporate revenues higher," said Steven Perry, Senior Executive Vice President at Cullman Mutual Capital. The Federal Reserve Chairman, Jerome Powell, suggested that the current economic outlook in the United States was "clearly brightened" on the back of the new economic data, which resulted as the fundamental catalyst of the rally across all major financial exchanges. Further commitment from the Federal Reserve was also reiterated as the central bank commented on its support to maintain its asset purchase programme until substantial progress has been made towards full employment within the United States. "The Fed's remarks combined with new economic data that was released has given investors new hope that this could be the economic rebound we have been looking for," added Masayoshi Higuchi, Chief Economist at Cullman Mutual Capital. More economic data is due in the upcoming weeks, with market analysts expecting more positive data to arrive, forecasting higher employment in the U.S. and more consumer spending as key signals to drive financial markets higher. About Cullman Mutual Capital Cullman Mutual Capital is a global asset management and institutional financial services business with a proactive attitude that delivers the results our client's demand. Founded in 2016, we have grown rapidly to 130+ staff, managing over $12 billion (USD) in assets. Working with diverse clients, including corporations and high-net-worth individuals, we provide high-quality asset and wealth management services for all. Our investments are with some of the largest global financial institutions, hedge funds, mutual funds, alongside other varied investment opportunities. To find out more about Cullman Mutual Capital, visit our website: www.cmcadvisory.com Media contact Company: Cullman Mutual Capital Company: Mr. Masayoshi Higuchi, Chief Economist E-mail: masayoshi.higuchi@cmcadvisory.com Telephone: +81 3 4563 8947 Address: 18F Sapia Tower, 1-7-12, Marunouchi, Chiyoda-ku, Tokyo, Japan SOURCE: Cullman Mutual Capital

Measures put forward include increasing the size and diversity of the organisation's membership.

The Nasdaq index fell more than 2% on Tuesday as steep declines in megacap growth stocks led Wall Street below record trading levels, with investors seeking shelter in more defensive parts of the market. Highly valued technology companies including Microsoft Corp , Alphabet Inc, Apple Inc, Amazon.com Inc and Facebook Inc fell between 0.6% and 2.4%.

Matt Friedlander walked into the White Horse Tavern, grabbed a seat at the polished wooden bar and let out a sigh of relief as he ordered a Budweiser and a glass of bourbon: A major pandemic restriction on drinking in New York City was finally gone. "Fourteen months since I've done this," the 39-year-old New Yorker said with an air of satisfaction as he sat on a bar stool, his Havanese and Pomeranian mix perched on the seat to his left. "42 inches high and it just feels right," he said, referring to the standard height of a bar.

The "Textured Soy Protein Market Size, Share & Analysis, By Form (Concentrates, Isolates, And Flour), By Type (Non-GMO, Conventional, And Organic), By Application (Food [Meat Substitutes, Dairy Alternatives, Infant Nutrition, Bakery] And Feed), And By Region, Forecast To 2028" report has been added to ResearchAndMarkets.com's offering.

The "Global EMV Cards Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Anthem BCBS in VA's State of the Nation's Mental Health report finds there wasn’t a corresponding increase in people seeking mental health treatment.

ETC Price Prediction: Is Ethereum Classic a Buy or Sell?

InvestingCube 04 May, 2021 - 04:01am

The Ethereum Classic price has surged in the past few days. ETC surged to an all-time high of $55. Its market cap has surged to more than $6.2 billion, while its overall ranking has surged to 27. On the other hand, Ethereum price has also surged to an all-time high of more than $3,000. 

What happened: In a note last week, I predicted that the Ethereum Classic price would soon break out. I pointed to the bullish flag that was forming and the overall outlook for Ethereum. I noted that ETC was similar to BCH in that they tend to derive their value from Ether and Bitcoin. 

Recently, Ethereum has done really well as many developers turn to the network. This has seen its price surge to an all-time high. Therefore, since a single Ether is substantially expensive than an ETC, many retail traders have moved to the latter. So, what next for ETC prices?

The daily chart shows that the ETC price has formed a bullish flag pattern that I talked about last week. In technical analysis, this is usually a bullish sign. The recent Ethereum price rally has seen its price surge above the upper side of the upward resistance level.

It has also moved above the short and longer-term moving averages. It has also moved above the previous all-time high of $49.90. Therefore, in my view, I suspect that the ETC price will keep rising as bulls attempt to move above $60. We can’t rule out a near-term pullback though.

Don’t miss a beat! Follow us on Telegram and Twitter.

Follow Crispus on Twitter.

Awarded and global FX/CFD broker. Well-regulated in multiple jurisdictions. Offers great spreads and liquidity for FX, Indices, and Commodities trading.

Cryptocurrency exchange with over 150 coins. As of Jan 18, Binance was the world's largest cryptocurrency exchange per volume.

Crispus Nyaga is a self-taught financial analyst and trader with more than seven years in the industry. He has worked for some of the biggest brokers in Europe and Australia as an analyst, coach, and course creator. He has a wealth of experience in equities, currencies, commodities, and global macroeconomic issues. He has also published for prominent financial publications like SeekingAlpha, Forbes, Investing.com, and Marketwatch. Crispus graduated with a Bachelor’s of Science in 2013, an MBA in 2017, and is currently working on an MSc in Financial Engineering from WorldQuant University. When he is not trading and writing, you can find him relaxing with his son.

Business Stories